I begge placebokontrollerede, dobbeltblindede undersøgelser fik patienter, som allerede fik medicinsk behandling for ITP i henhold til en konstant doseringsplan, lov til at fortsætte med disse medicinske behandlinger under hele undersøgelsen (kortikosteroider, danazol og/ eller azathioprin).
In both placebo-controlled, double-blind studies, patients already receiving ITP medical therapies at a constant dosing schedule were allowed to continue receiving these medical treatments throughout the study (corticosteroids, danazol and/ or azathioprine).